, Volume 39, Issue 1, pp 77–81 | Cite as

Prolonged QT interval as a predictor of mortality in diabetic nephropathy

  • P. T. Sawicki
  • R. DÄhne
  • R. Bender
  • M. Berger


Patients with diabetic nephropathy face an increased risk of dying due to cardiac causes. The aim of this follow-up trial was to describe the association between the length of the QT interval, as a marker of myocardial electrical stability, and the risk of death in insulin-dependent (IDDM) diabetic patients with overt diabetic nephropathy. A consecutive sample of 85 IDDM patients with overt diabetic nephropathy (i. e. persistent proteinuria ≥ 500 mg/24 h) were followed-up until death or for a period of 5–13 years. QT intervals were measured once at baseline in a 12-lead ECG and corrected for heart rate (QTc). During the follow-up period 33 patients (39%) died. In the Cox proportional hazards model independent predictors of death were age (p=0.0007), the length of the maximum QTc period (p=0.0049), presence of autonomic neuropathy (p=0.0068), diabetes duration (p=0.0163) and RR variation (p=0.0395). In conclusion, in nephropathic IDDM patients QT prolongation is associated with an increased mortality risk which is independent of the presence of autonomic neuropathy. Further studies are needed to determine whether this risk might be reduced by therapeutic interventions.

Key words

Diabetic nephropathy diabetic autonomic neuropathy QT interval hypertension mortality 



Insulin-dependent diabetes mellitus


QT intervals corrected for heart rate


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Borch-Johnsen K, Kreiner S, Deckert T (1986) Mortality of type 1 (insulin-dependent) diabetes mellitus in Denmark: a study of relative mortality in 2930 Danish type 1 diabetic patients diagnosed from 1933 to 1972. Diabetologia 29: 767–772PubMedGoogle Scholar
  2. 2.
    Borch-Johnson K, Kreiner S (1987) Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. BMJ 294: 1651–1654PubMedGoogle Scholar
  3. 3.
    Ewing DJ, Campbell IW, Clarke BF (1976) Mortality in diabetic autonomic neuropathy. Lancet I:601–603CrossRefGoogle Scholar
  4. 4.
    Page MMcB, Watkins PJ (1978) Cardiorespiratory arrest and diabetic autonomic neuropathy. Lancet I:14–16Google Scholar
  5. 5.
    Pont A, Rushing JL, Kelsey T, Jacobs L (1978) Cardiorespiratory arrest in diabetic neuropathy. Lancet I:386–387CrossRefGoogle Scholar
  6. 6.
    Garcia-Bunuel L (1978) Cardiorespiratory arrest in diabetic neuropathy. Lancet I:935–936CrossRefGoogle Scholar
  7. 7.
    Srinivasan G, Sanders G (1978) Cardiorespiratory arrest in diabetes. Lancet I:504–505CrossRefGoogle Scholar
  8. 8.
    Ong JJC, Sarma JSM, Venkataraman K, Levin SR, Singh BN (1993) Cardiac rhythmicity of heart rate and QTc interval in diabetic autonomic neuropathy: implications for the mechanism of sudden death. Am Heart J 125: 744–752CrossRefPubMedGoogle Scholar
  9. 9.
    Bexton RS, Vallin HO, Camm AJ (1986) Diurnal variation of the QT interval-influence of the automatic nervous system. Br Heart 55: 253–258Google Scholar
  10. 10.
    Browne KF, Zipes DP, Heger JJ, Prystowsky EN (1982) Influence of the autonomic nervous system on the QT interval in man. Am J Cardiol 50: 1099–1103PubMedGoogle Scholar
  11. 11.
    Ahnve S, Vallin H (1982) Influence of heart rate and inhibition of autonomic tone on the QT interval. Circulation 65: 435–439PubMedGoogle Scholar
  12. 12.
    Vlay SC, Mallis GI, Brown EJ, Cohn PF (1984) Documented sudden cardiac death in prolonged Q-T syndrome. Arch Intern Med 144: 833–834CrossRefPubMedGoogle Scholar
  13. 13.
    Barr CS, Naas A, Freeman M, Lang C, Struthers AD (1994) QT dispersion and sudden unexpected death in chronic heart failure. Lancet 343: 327–329CrossRefPubMedGoogle Scholar
  14. 14.
    Jensen T, Borch-Johnsen K, Koefoed-Enevoldsen A, Deckert T (1987) Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia 30: 144–148CrossRefPubMedGoogle Scholar
  15. 15.
    MØlgaard H, Christensen PD, Hermansen K, SØrensen KE, Christensen CK, Mogensen CE (1994) Early recognition of autonomic dysfunction in microalbuminuria: significance for cardiovascular mortality in diabetes mellitus? Diabetologia 37: 788–796CrossRefPubMedGoogle Scholar
  16. 16.
    Puddu PE, Bourassa MG (1986) Prediction of sudden death from QTc interval prolongation in patients with chronic ischemic heart disease. J Electrocardiology 19: 203–211Google Scholar
  17. 17.
    Bellavere F, Ferri M, Guarini et al. (1988) Prolonged QT period in diabetic autonomic neuropathy: a possible role in sudden cardiac death. Br Heart J 59: 379–383PubMedGoogle Scholar
  18. 18.
    Ewing DJ, Boland O, Neilson JMM, Cho CG, Clarke BF (1991) Autonomic neuropathy, QT interval lenthening, and unexpected deaths in male diabetic patients. Diabetologia 34: 182–185PubMedGoogle Scholar
  19. 19.
    Jermendy G, Tóth L, Vörös P, Koltai MZ, Pogátsa G (1991) Cardiac autonomic neuropathy and QT interval length. A follow-up study in diabetic patients. Acta Cardiol 46: 189–200PubMedGoogle Scholar
  20. 20.
    MØlgaard H, Christensen PD, SØrensen KE, Christensen CK, Mogensen CE (1992) Association of 24-h cardiac parasympathetic activity and degree of nephropathy in IDDM. Diabetes 41: 812–817PubMedGoogle Scholar
  21. 21.
    Internationale Klassifikation der Krankheiten (ICD) (1993) 9th Revision, 2nd edn. Kohlhammer, CologneGoogle Scholar
  22. 22.
    Day CP, James OFW, Butler TJ, Campbell RWF (1993) QT prolongation and sudden cardiac death in patients with alcoholic liver disease. Lancet 341: 1423–1428CrossRefPubMedGoogle Scholar
  23. 23.
    Sawicki PT, Heinemann L, Berger M (1989) Comparison of methods for determination of microalbuminuria in diabetic patients. Diabet Med 6: 412–415PubMedGoogle Scholar
  24. 24.
    Ewing DJ (1984) Cardiac autonomic neuropathy. In: Jarrett J (ed) Diabetes and heart disease. Elsevier, New York, pp 99–132Google Scholar
  25. 25.
    Cox DR (1972) Regression models and life tables (with discussion). J R Statist Soc B 34: 187–220Google Scholar
  26. 26.
    SAS (1987) SAS/STAT guide for personal computers. Version 6 edition. SAS Institute Inc., Cary, N. C.Google Scholar
  27. 27.
    SAS (1988) SAS technical report P-179, additional SAS/STAT procedures. Release 6.03. SAS Institute Inc., Cary, N.C.Google Scholar
  28. 28.
    SAS (1991) SAS technical report P-217, SAS/STAT software. The PHREG procedure, version 6. SAS Institute Inc., Cary, N.C.Google Scholar
  29. 29.
    Parving HH, Hommel E (1989) Prognosis in diabetic nephropathy. BMJ 299: 230–233PubMedGoogle Scholar
  30. 30.
    Mathiesen ER, Borch-Johnsen K, Jensen DV, Deckert T (1989) Improved survival in patients with diabetic nephropathy. Diabetologia 32: 884–886CrossRefPubMedGoogle Scholar
  31. 31.
    MØlgaard H, Mickley H, Pless P, Bjerregaard P, MØller M (1993) Effects of metoprolol on heart rate variability in survivors of acute myocardial infarction. Am J Cardiol 71: 1357–1359CrossRefPubMedGoogle Scholar
  32. 32.
    Wilkstrand J, Kendall M (1992) The role of beta receptor blockade in preventing sudden death. Eur Heart J 13[Suppl D]:111–120Google Scholar
  33. 33.
    Kjekshus J, Glipin E, Cali G, Blackey AR, Henning H, Ross J Jr (1990) Diabetic patients and beta-blockers after myocardial infarction. Eur Heart J 11: 43–50Google Scholar

Copyright information

© Springer-Verlag 1996

Authors and Affiliations

  • P. T. Sawicki
    • 1
  • R. DÄhne
    • 1
  • R. Bender
    • 1
  • M. Berger
    • 1
  1. 1.Medical Department of Metabolic Diseases and Nutrition (WHO Collaborating Centre for Diabetes)Heinrich-Heine UniversityDüsseldorfGermany

Personalised recommendations